These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35699843)
1. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India. Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK; Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Multisystem Inflammatory Syndrome in Children. McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M; N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854 [TBL] [Abstract][Full Text] [Related]
3. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG; N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855 [TBL] [Abstract][Full Text] [Related]
4. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F; JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115 [TBL] [Abstract][Full Text] [Related]
5. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals. Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S; Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394 [TBL] [Abstract][Full Text] [Related]
6. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India. Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462 [TBL] [Abstract][Full Text] [Related]
7. Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021. Shah AB; Abrams JY; Godfred-Cato S; Kunkel A; Hammett TA; Perez MA; Hsiao HM; Baida N; Rostad CA; Ballan W; Ede K; Laham FR; Kao CM; Oster ME; Belay ED Pediatr Infect Dis J; 2023 Nov; 42(11):990-998. PubMed ID: 37862698 [TBL] [Abstract][Full Text] [Related]
8. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome. Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681 [TBL] [Abstract][Full Text] [Related]
9. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children. Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042 [TBL] [Abstract][Full Text] [Related]
12. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults. Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368 [TBL] [Abstract][Full Text] [Related]
13. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India. Jain S; Sen S; Lakshmivenkateshiah S; Bobhate P; Venkatesh S; Udani S; Shobhavat L; Andankar P; Karande T; Kulkarni S Indian Pediatr; 2020 Nov; 57(11):1015-1019. PubMed ID: 32788432 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Bagri NK; Deepak RK; Meena S; Gupta SK; Prakash S; Setlur K; Satapathy J; Chopra K; Upadhyay AD; Ramakrishnan S; Lodha R; Dar L; Trikha A; Kabra SK Rheumatol Int; 2022 Mar; 42(3):477-484. PubMed ID: 34665296 [TBL] [Abstract][Full Text] [Related]
15. Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU. Chattopadhyay A; Saigal Kalra K; Saikia D; Yadav V; Chouksey J; Jajoo M; Sherwal BL J Intensive Care Med; 2022 Sep; 37(9):1229-1237. PubMed ID: 35469487 [No Abstract] [Full Text] [Related]
16. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review. Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964 [TBL] [Abstract][Full Text] [Related]
17. Cardiac Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome. Ghodsi AR; Malek A; Siroosbakht S; Aminian A; Dormanesh B; Azarfar A; Zoshk MY Indian Pediatr; 2023 May; 60(5):381-384. PubMed ID: 37161459 [TBL] [Abstract][Full Text] [Related]
18. Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021. Abrams JY; Belay ED; Godfred-Cato S; Campbell AP; Zambrano LD; Kunkel A; Miller AD; Wu MJ; Meng L; Shah AB; Oster ME Clin Infect Dis; 2022 Sep; 75(7):1201-1209. PubMed ID: 35100610 [TBL] [Abstract][Full Text] [Related]
19. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India. Gupta Dch S; Chopra Md N; Singh Md A; Gera R; Chellani Md H; Pandey PhD R; Arora Md BS J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33513240 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. Channon-Wells S; Vito O; McArdle AJ; Seaby EG; Patel H; Shah P; Pazukhina E; Wilson C; Broderick C; D'Souza G; Keren I; Nijman RG; Tremoulet A; Munblit D; Ulloa-Gutierrez R; Carter MJ; Ramnarayan P; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Blyuss O; Levin M; Lancet Rheumatol; 2023 Apr; 5(4):e184-e199. PubMed ID: 36855438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]